MetLife Investment Management, LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2021$235,575
-42.2%
23,892
-36.5%
0.00%
-50.0%
Q4 2020$407,757
+5.2%
37,6160.0%0.00%0.0%
Q3 2020$387,445
-43.1%
37,616
+15.4%
0.00%
-50.0%
Q2 2020$680,792
+144.0%
32,605
+14.2%
0.01%
+100.0%
Q1 2020$279,002
-15.2%
28,5570.0%0.00%
+33.3%
Q4 2019$328,977
+111.4%
28,5570.0%0.00%
+50.0%
Q3 2019$155,636
-54.2%
28,5570.0%0.00%
-50.0%
Q2 2019$339,543
+126.9%
28,5570.0%0.00%
+100.0%
Q1 2019$149,639
-12.7%
28,557
+0.8%
0.00%0.0%
Q3 2018$171,463
+14.3%
28,3410.0%0.00%0.0%
Q2 2018$150,00028,3410.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2018
NameSharesValueWeighting ↓
Casdin Capital, LLC 420,000$1,134,0000.67%
EcoR1 Capital, LLC 874,447$2,361,0000.60%
VHCP Management II, LLC 280,000$756,0000.31%
683 Capital Management, LLC 350,000$945,0000.15%
AWM Investment Company, Inc. 400,000$1,080,0000.10%
JW Asset Management, LLC 178,654$482,0000.10%
TFS CAPITAL LLC 89,156$241,0000.08%
Rhenman & Partners Asset Management AB 154,006$416,0000.07%
SABBY MANAGEMENT, LLC 282,630$763,0000.04%
Numeric Investors LLC 1,087,967$2,938,0000.03%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders